NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000962

Registered date:01/01/2008

Phase II study of neoadjuvant chemotherapy TS-1/CPT-11 for advanced lower rectal cancers

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedRectal cancers
Date of first enrollment2007/10/01
Target sample size25
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Chemotherapy Surgery

Outcome(s)

Primary Outcome3-year disease-free survival rates
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaExcluded are cases with conditions as below: 1) Multiple malignancies to be treated. 2) Previous history of severe drug-induced allergy. 3) Active infectious diseases. 4) Coexistent severe diseases including pulmonary fibrosis, interstitial pneumonia, ileus, uncontrollable diabetes, cardiac dysfunction, hepatic failure, or renal failure. 5) Peritoneal or pleural fluid retention to be drainaged. 6) Symptomatic brain metastases. 7) Active digestive tract bleeding. 8) Severe watery diarrhea. 9) Pregnant. 10) Previous treatment history of radiotherapy.

Related Information

Contact

public contact
Name
Address Japan
Telephone 075-751-3227
E-mail
Affiliation Kyoto University Hospital Surgery
scientific contact
Name Satoshi Nagayama
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto City Japan
Telephone
E-mail
Affiliation Kyoto University Hospital Surgery